tetano
Editor, Senior Moderator
NPJ Vaccines. 2017 Dec 4;2:33. doi: 10.1038/s41541-017-0034-4. eCollection 2017.
[h=1]Newcastle disease virus-based H5 influenza vaccine protects chickens from lethal challenge with a highly pathogenic H5N2 avian influenza virus.[/h] Ma J[SUP]#[/SUP][SUP]1,[/SUP][SUP]2[/SUP], Lee J[SUP]#[/SUP][SUP]1[/SUP], Liu H[SUP]1[/SUP], Mena I[SUP]3,[/SUP][SUP]4[/SUP], Davis AS[SUP]1[/SUP], Sunwoo SY[SUP]1[/SUP], Lang Y[SUP]1[/SUP], Duff M[SUP]1[/SUP], Morozov I[SUP]1[/SUP], Li Y[SUP]1[/SUP], Yang J[SUP]1,[/SUP][SUP]5[/SUP], Garc?a-Sastre A[SUP]3,[/SUP][SUP]4,[/SUP][SUP]6[/SUP], Richt JA[SUP]1[/SUP], Ma W[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Since December 2014, Eurasian-origin, highly pathogenic avian influenza H5 viruses including H5N1, H5N2, and H5N8 subtypes (called H5Nx viruses), which belong to the H5 clade 2.3.4.4, have been detected in U.S. wild birds. Subsequently, highly pathogenic H5N2 and H5N8 viruses have caused outbreaks in U.S. domestic poultry. Vaccination is one of the most effective ways to control influenza outbreaks and protect animal and public health. Newcastle disease virus (NDV)-based influenza vaccines have been demonstrated to be efficacious and safe in poultry. Herein, we developed an NDV-based H5 vaccine (NDV-H5) that expresses a codon-optimized ectodomain of the hemagglutinin from the A/chicken/Iowa/04-20/2015 (H5N2) virus and evaluated its efficacy in chickens. Results showed that both live and inactivated NDV-H5 vaccines induced hemagglutinin inhibition antibody titers against the H5N2 virus in immunized chickens after prime and booster, and both NDV-H5 vaccines completely protected chickens from lethal challenge with the highly pathogenic H5N2 A/turkey/Minnesota/9845-4/2015 virus. No clinical signs and only minimal virus shedding was observed in both vaccinated groups. In contrast, all mock-vaccinated, H5N2-infected chickens shed virus and died within 5 days post challenge. Furthermore, one dose of the live NDV-H5 vaccine also provided protection of 90% chickens immunized by coarse spraying; after exposure to H5N2 challenge, sera from vaccinated surviving chickens neutralized both highly pathogenic H5N1 and H5N8 viruses. Taken together, our results suggest that the NDV-based H5 vaccine is able to protect chickens against intercontinental highly pathogenic H5Nx viruses and can be used by mass application to protect the poultry industry.
PMID: 29263888 PMCID: PMC5714955 DOI: 10.1038/s41541-017-0034-4
[h=1]Newcastle disease virus-based H5 influenza vaccine protects chickens from lethal challenge with a highly pathogenic H5N2 avian influenza virus.[/h] Ma J[SUP]#[/SUP][SUP]1,[/SUP][SUP]2[/SUP], Lee J[SUP]#[/SUP][SUP]1[/SUP], Liu H[SUP]1[/SUP], Mena I[SUP]3,[/SUP][SUP]4[/SUP], Davis AS[SUP]1[/SUP], Sunwoo SY[SUP]1[/SUP], Lang Y[SUP]1[/SUP], Duff M[SUP]1[/SUP], Morozov I[SUP]1[/SUP], Li Y[SUP]1[/SUP], Yang J[SUP]1,[/SUP][SUP]5[/SUP], Garc?a-Sastre A[SUP]3,[/SUP][SUP]4,[/SUP][SUP]6[/SUP], Richt JA[SUP]1[/SUP], Ma W[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Since December 2014, Eurasian-origin, highly pathogenic avian influenza H5 viruses including H5N1, H5N2, and H5N8 subtypes (called H5Nx viruses), which belong to the H5 clade 2.3.4.4, have been detected in U.S. wild birds. Subsequently, highly pathogenic H5N2 and H5N8 viruses have caused outbreaks in U.S. domestic poultry. Vaccination is one of the most effective ways to control influenza outbreaks and protect animal and public health. Newcastle disease virus (NDV)-based influenza vaccines have been demonstrated to be efficacious and safe in poultry. Herein, we developed an NDV-based H5 vaccine (NDV-H5) that expresses a codon-optimized ectodomain of the hemagglutinin from the A/chicken/Iowa/04-20/2015 (H5N2) virus and evaluated its efficacy in chickens. Results showed that both live and inactivated NDV-H5 vaccines induced hemagglutinin inhibition antibody titers against the H5N2 virus in immunized chickens after prime and booster, and both NDV-H5 vaccines completely protected chickens from lethal challenge with the highly pathogenic H5N2 A/turkey/Minnesota/9845-4/2015 virus. No clinical signs and only minimal virus shedding was observed in both vaccinated groups. In contrast, all mock-vaccinated, H5N2-infected chickens shed virus and died within 5 days post challenge. Furthermore, one dose of the live NDV-H5 vaccine also provided protection of 90% chickens immunized by coarse spraying; after exposure to H5N2 challenge, sera from vaccinated surviving chickens neutralized both highly pathogenic H5N1 and H5N8 viruses. Taken together, our results suggest that the NDV-based H5 vaccine is able to protect chickens against intercontinental highly pathogenic H5Nx viruses and can be used by mass application to protect the poultry industry.
PMID: 29263888 PMCID: PMC5714955 DOI: 10.1038/s41541-017-0034-4